| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |